Skip to content

Hinge Health

US · HNGE #1682 by market cap Listed 2025
105.78 -2.32 -2.15%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Price chart

Pre-market 107.00 -1.02%
After-hours 106.00 +0.21%
123.2352.98105.782026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on HNGE?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Bullish
  • Recent price momentum is +78.4% on average (3-month/1-year).
  • Main-fund capital flow has been a net inflow over the last 45 sessions.
  • Short interest has risen to 6.2% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Neutral
  • Price is below its 20-day average and above its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days B → C

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-22 08:27 UTC

Data coverage: 5 of 6 factors. Missing data is not a zero score.

Overall B-

The radar needs all six factors. Available grades are shown below.

Valuation D-

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 51.7x Better than 9%
Forward P/E 43.3x Better than 9%
Price / Sales 11.7x Better than 9%
P/E vs own 5-yr range 83rd pctl Better than 23%
Growth N/A

How fast revenue, profit and free cash flow are compounding.

Not enough data to grade this factor.

Profitability C

How much profit the business keeps from each dollar of sales and capital.

Gross margin 79.6% Better than 90%
Operating margin -92.9% Better than 7%
Net margin -72.1% Better than 8%
Momentum A+

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return 19.6% Better than 96%
6-month return 91.5% Better than 99%
12-month return (ex latest month) 142.5% Better than 97%
Distance below 52-week high 16.3% Better than 68%
Financial Health A-

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 1.5x Better than 40%
Debt to assets 1.1% Better than 92%
Analyst View B

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 100.0% Better than 77%
Upside to average target 24.7% Better than 41%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -8.33%
1M -1.61%
3M +23.55%
6M +93.24%
YTD +127.73%
1Y +133.20%

Key statistics

Price & volume

Prev close
108.10
Open
107.05
Day range
103.12 - 109.18
Avg price
105.72
Volume
1.65M
Turnover
174.41M
Amplitude
5.61%
52-week range
30.08 - 126.40

Valuation

P/E
-19.75
P/E (TTM)
51.68
P/B
28.71
EPS
-5.36
Net profit
-435.37M
Net assets
299.40M

Share structure

Market cap
8.60B
Float cap
5.36B
Shares out
81.27M
Float shares
50.63M

Dividend & listing

Dividend (TTM)
0.00
Listing date
2025-05-22
52-week range 79% of range
30.08 126.40

16.3% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

+17.99M net over the window

Short interest

Shares short
4.98M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Hinge Health (HNGE)?

Hinge Health last traded at 105.78. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Hinge Health's market cap?

About 8.60B.

What is the P/E ratio of Hinge Health?

The trailing twelve-month P/E is 51.68, above its own 5-year average of 9.98 — toward the top of its historical range (82.89% percentile). See the Valuation tab for the full history.

Does Hinge Health pay a dividend?

Hinge Health does not currently pay a regular dividend.

Is Hinge Health a buy according to analysts?

The consensus of 11 analysts is a Buy rating, with an average 12-month price target of 131.88, which implies 24.7% upside from the current price. This is not investment advice.

What is Hinge Health's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Hinge Health a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 20:02:33 · For reference only, not investment advice and not tailored to your situation.

Hinge Health discussion 0 comments

Add a comment